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·INTRODUCTION

Agranulocytic Angina for the past seventeen years
has been highly discussed both in medical centers and
in literature.

During this time the understanding of

the disease has developed in the curriculum of the
medical profession.

Since 1922, when first described

as a clinical entity by Schultz, it has been reported
more frequently as the years passed until at the
present time agranulocytosis is recognized widely as
a disease process.
Just as with the development of any medical
problem this has been laden with various opinions on
its course, etiology, etc., all of which has served to
confuse the searching medical mind as to its true
standing.

At the present time the literature is still

presenting widely divergent views as to its interrelationships.
Arter a review of the literature, both from a
clinical and an experimental angle, it has occurred to
me that many of these rival views are in reality not
such at all, but merely congruent or parallel facts or
conclusions which are really more supportive than
actually contradictory in nature.
While conducting experimental work in benzol
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poisoning, an entity which closely simulates granulopenia, my interest in agranulocytic angina was first
stimulated.

The results of these experiments will not

appear in this paper, but in a later paper.

While

working in this field, I was impressed with the argumentative basis of malignant neutropenia.

This thesis

is an attempt to bring together more closely these
wandering views and to tie them together more fil'mly
toward a central thought, that of agranulocytosis itself.
The following will deal primarily with the clinical side
of the question, bringing in experimental work only as
a supportive measure to the clinical case.

DEFINITION
Agranulocytosis is a disturbance, constant or intel."mittent, chronic or acute, severe or mild, of the hematopoietic system, caused by various known or unknown
factors.

Clinically, i.t is more than a disease, fall-

ing more accurately in the classification of a syndrome.
Characteristically, it incorporates a febrile course
associated with ulcerative lesions of the mucous
membranes, especially of the oral cavity, and a complete,
or almost complete, disappearance of the granulocytin
element from the circulating or peripheral blood stream.
Mortality rates in this syndrome are high but are
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decreasing with the advent of new therapeutic measures.
Synonyms by which the entity is known are:
granulocytopenia, granulopenia, agranulocytic angina,
malignant neutropenia, idiopathic neutropenia and
pernicious neutropenia.

HI Br ORY
The disease, or at least its modern conception,
was first described by Schultz, a German writer, in
1922.

However, we have the actual condition being

referred to fi:rty years ago when standard laryngological
works described the entity under the heading of "putrid
sore throat" or "gangrenous angina".

MacKenzie, in his

manual of diseases of the throat and nose, credited
Guber in 1857 and Trousseau in 1865 with having clearly
distinguished the disease from diphtheria (7).
MacKenzie and Marrel discussed a condition similar to
the. modern clinical conception in that they pointed out
the stomadico-pharyngeal lesions and differentiated this
condition from other lesions of the same area such as
diphtheria, scarlet fever, etc. (93).
In 1902 Brown, although he did not describe the
case under any of its present nomenclature, reviewed a
typical case in a debilitated woman following a cervical
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operation.

He found the· typical stomatitis and ulcer-

ative lesions of this region associated with an enlarged
liver.

He reported a low white blood count and a

differential which showed a complete lack of polymorphonuclear-neutrophelic leucocytes.

At autopsy en-

larged lymph glands were found in the cervical region.
Blood specimens taken from various parts of the body
showed no neutrophils.
not done. (15)

A bone marrow examination was

Turk in 1907 reported what appeared to

be a similar case, but he did not distinguish the
disease from others. (51).
Leale described a clinical case in 1910 of a baby,
age

3i

months, with a white count of 3000, mostly

lymphocytes.

In fact, the polymorphonuclear count

showed these cells to be only one percent.

This case

developed as a periodic fever accompanying furuncles
and marked prostration.
for one year's duration.

It was recurrent in this manner
The child was given immuniz-

ing vaccine which apparently cured him of his malady.(72)
Cases were described even before this date to quite
an accurate extent as shown by Senator's article in 1888
and by Baldridge and Needles' paper in 1902.

In 1913

Larson and Barron reported what seemed to be a typical
case of agranulocytosis with ulceration of the upper
jaw.

The patient died a septic death.
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They considered

rthe fusiform bacillus as an etiological factor.

This

was the first mention of the etiology of the disease.
It is interesting to note that many observers hold this
to be an etiological factor today, and yet it was suggested before the actual description of the syn.drome.(71)
It was not until 1922 when Schultz accurately described the disease and gave six oases that the attention
of the medical profession was focused upon this condition.
The importance of Schultz's observations, outside of
calling forth attention and accurately recognizing the
condition, was that he emphasized the fact that the red
blood cells seemed to be little, if any, affected. (33).
It is of interest to note that the first case in
this country was described by Lovett in 1924.

He

pointed out a reduction of white blood cells, chiefly
of the neutrophilic variety, no anemia, and also a lac k
of neutrophils in the bone marrow.

He accurately de-

scribed the clinical symptoms and signs and stated that
a cellular reaction to the local pharyngeal lesions was
lacking.

In addition, B.pyocyaneus, having been iso-

lated from the spleen and local lesions, produced a low
white blood count when injected into guinea pigs. (76).
Of further historical interest is the development
of therapy in this field.

The use of blood trans-

fusions has long been, recognized as a beneficial and
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supportive treatment and a possible stimulative element
in some blood dyscrasias.

For these reasons trans-

fusions have been a partial treatment of this disease.
In late years liver therapy has been inaugurated into
the therapy.

Likewise, X-Ray treatment of the long

bones has been and is used still as an aid in this condition.

Its origin and use is obscure since this is a

factor Roentgenologists have been taking advantage of
for years_ in the treatment of certain blood dyscrasias.
Of more historical interest is the use of nucleic
acid and its derivatives.

This was first advocated by

Huntley and .Ames in 1897.

However, we find that Vaughn

as early as 1893 suggested nucleic acid as a treatment
for leucopenia.

Since then it has been used quite

extensively from time to time, mostly upon a theoretical basis.

In 1924 Jackson demonstrated pentnucleotidis

as being norm.ally present in the blood.

Reznikoff in

1930 used this substance with benef'i,cial results on six
patients, and Jackson in 1931 said that clinical results
were gained in 4-5 days, the blood picture being improved in 4-7 days.

The excellent work of Doan in

demonstrating its effect on the blood has proven conclusively its beneficial results. (33)
During the past year a new treatment with yellow
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bone marrow extract has been subjected which seems to
give even greater beneficial results.
Since Schultz's work in 1922 a voluminous amount
of literature and experimentation has been done which
seems to be growing with each succeeding year.

As this

is not important historically, the body of this paper
will deal with the essential points of this material
as they arise.

ErIOLOGY
The factors, both related and direct, which cause
this disease are represented by a long list reported
from several investigators.

Many of these are the

results of inductive and deductive logic.

Some are

backed by actual clinical" material while a few have
scientific experimentation to prove more or less conclusively their connection.
When the condition was first described, the sole
cause was thought to be the peripheral effect of a
circulating toxin or toxins of bacteria or else the
paralytic effect of the same on bone marrow causing
the hematopoietic tissue to become non-productive.
This view is still held by some, but many others believe
that the bacterial infection is only a complication made
readily accessible by the lowered absolute count of the

7.

polym.orphonuclear neutrophilic leucocytes. (65)
For purposes of discussion the subject may be
divided into several parts:
I.

Predisposing causes:
It was at first reported that women between the

ages of forty and fifty were the ones most likely to
contract the disease.

Figures now show that only 56%

are female patients, which data seems to rule out the
predisposing factor of women as contrasted to men.

It

is still most prevalent, however, in middle life.
The disease primarily affects the white race.
Another factor is shown in that it has been found to
arise many times coincident with previous diseases of
the liver and gall bladder.
The use of drugs containing the benzene ring, the
arsenicals, mesothorium, trinitrotoluene, X-Ray, and
the Gamma rays of radium seem to affect the bone marrow
in such a way as to simulate this entity ( ?) •
II. Organisms as a cause:
The theory of a latent infection, which has been
present for a long time, is superimposed by a new
emergency with which the depressed bone marrow is unable
to cope.
Many investigators believe that often the primary

a.

rinfection is in the bone marrow or in the blood, or
both, with the result of a marked leuoopenia. (7).

In

support of this latter view it has been found that
rabbits in which a hematogenous infection of Talmonella
surpestifer has been produced often show agranulocytosis.
This is accompanied by intense necrosis of the bone
marrow without signs of regeneration.(26)
Other organisms have been isolated from the blood
stream in this condition.

These are usually the organ-

isms of the mouth such as Streptococci hemolyticus and
viridans, various Staphylococci, etc.

The most constant

offender found in the blood stream in this disease is
Vincents' organism. (66).
Linthicum produced the disease in 1927 by injecting B.pyocyaneus, isolated from the throat of a woman
suffering from granulopenia, into a guinea pig which
resulted in a lowered white blood count. (75)

However,

Kracke demonstrated that in a large list of clinical
and experimental cases the pathology was always first
noted in the bone marrow.
white count.

This was followed by a low

The infection was always a complication

and followed the lowering of the peripheral circulating
neutrophils. (54)

,,,......-,
'
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III. Septic and Toxic Processes:
Stocke believes that neutropenia is not a special
disease but an abnormal reaction to sepsis.

In contra-

diction to this view Zadek believes that a virus or
bacterial-toxin of sufficient potency to destroy the
granulopoietic tissue so completely would not spare so
uniformly the closely related contiguous cells. (7)
Stocke's explanation is regarded by many investigators as a very plausible one.

Many typical cases

show a localized mouth infection and suggest a virulent
circulating toxin which destroys the leucocytes of the
blood and bone marrow. (62)

Roberts and Kracke were

unable to demonstrate any circulating agent which would
affect the blood cells.

After mixing normal blood with

the serum of a diseased patient, they found no change
in the cells after various periods of incubation. (105)
Blumer, however, reported a case in which agranulocytosis developed after sepsis was present. (12)
The whole problem of bacterial toxins as an entity
in the production seems to be highly disputed.

One

investigator claims to have produced granulocytopenia
by porous bags transplanted within the abdominal cavity.
In these the bacterial culture was placed.

The toxin

could diffuse out, but the bacteria could not.

Injections

of the same bacteria would not cause granulopenia but
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rather a typical septic rise in the white blood picture.
No one has been able to reproduce his results.
IV.

Hyperergic Inflammation.
Schilling believes that the phenomenon may be caused

by a form of allergy in which the bone marrow is the
point of least resistance.

As a partial support of this

view, Bromberg, Murphy and Kracke have observed the condition a:rter prophylactic injection of typhoid toxoid (?).
Patch tests on persons who have been suspected of having
amidopyrine as the etiological factor sometimes shows
an hypersensitivity with the same drug. (39).
V.

Congenital and Familial Anomaly:
Hart, a:rter observing malignant neutropenia in

two sisters, suggested familial tendency.

On the other

hand, Wolf suggested a familial weak hemopoietic system
when he observed a brother and sister, one with neutropenia and the other with myeloblastic leukemia.

This

latter view is held by Bickel (7).
VI.

Chemical Poisoning.
This includes the entire class of drugs which may

serve to weaken the hemopoietic tissue.
produce a true agranulocytosis.

Many do not

For example, benzene

usually does not produce a typical benign or malignant
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neutropenia but rather a depression of all the bone
marrow elements; so.that anemia, purpura, and sometimes
methemoglobemia as well as leucopenia and neutropenia
are produced.(?).

Many others have been reported such

as arsphenamine by Talley and Griffith, Kastlin, and
others; gold preparations by Jacob and Dowody; arsenic
by Dodd and Wilkinson, Wheelihan and Farley; mustard
gas by Krum.bhaar; and sulphanilam.ide recently by McGuire
and others.

Later, this list of drugs together with

others producing agranulocytosis will be considered
more thoroughly.
VII. Endogenous Disturbances; Production of Chemotactic
and Maturation Factors.
It is known that two different processes are
necessary to maintain production and amount of granulocytes in the circulation: (1) maturation, and (2)
delivery to circulation.

Animal experimentation, there-

fore, might be carried on by removing different glands
of internal secretion.

This might reveal valuable infor-

mation concerning etiology and treatment.(?).

For

example, Richardson in 1933 reported agranulocytosis as
being present in one of his patients who had Carcinoma
of the Pancreas.

He believe that this might be caused

by toxins liberated from the growth ( 104).
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Some investigators have advanced the theory that
toxins from bacteria might act in such a way as to
paralyze the stimulating endocrines which stimulate the
bone marrow either for maturation or delivery to the
peripheral blood channels. (5).
Other endocrine disturbances of marrow function
have been noted.

Hubble reported bone marrow depression

accompanying pituitary basophilic insufficiency.

Button

and Corey produced neutro})enia with adrenal insufficiency
with a subsequent return to normal when the animal was
fed cortico-adrenal extract.

In thyroidectomized

rabbits there ensued an aplastic anemia according to
Kuncle et al (64).
Another important etiological agent is radiation.
X-Ray in small doses tends to stimulate the hemopoietic
centers but in moderate a.nd large doses tends to destroy
the genninal blood cells.

Radium, thorium, X-Ray, and

other radiating materials have a like effect.

In

supporting this belief Kracke stated that the disease
is predominantly one of the white race, negroes being
little affected.

"Perhaps", he states, "it is due to

the greater susceptability of the white skin to radiations from the sun".

This investigator was firmly

convinced that most cases show a history of some chemical
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toxin, or X-Ray, etc.

He advanced some interesting

statistics to hold forth his belief.
The disease has been high in incidence in both the
United States and Germany where these drugs are sold
most frequently.

On the other hand, countries which do

not vend these drugs to a very great extent have a low
incidence.

Also it is a disease of the "better class".

And finally it is found most pronounced in the medical
and associated professions, for here are the greatest
offenders, if such be the case, of the consumption of
products of the benzene ring.

There are fifty times as

many physicians as lawyers and one hundred times as many
nurses as ·female teachers who suffer from the malady (64).
Other factors of etiologic importance have been.
listed:

(a) Menstruation: Cases of women who have

periodic attacks every twenty-eight days have been
reported;

(b) Fatigue: Many cases which give a history

of restlessness, overwork, sleeplessness, or work. (18);
(c) Pregnancy has been observed as a possible precursor
of the disease. (66).
Aside from all these etiological factors of known
or surmised value, there are found many cases of obscure
origin.

These are the so-called idiopathic agranu-

locytoses.

Why?

Is there an increased peripheral
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destruction, an abnormal distribution, or a failure of
cell development?

There is no evidence of increased

peripheral destruction.

The spleen is a little enlarged

and the red cells are not disturbed.

Likewise, there

is no evidence of abnormal distribution of cells.
Kracke in checking blood counts distributed over
the entire body, both in venous and capillary systems,
finds no striking deviation from Garrey's work, which
shows a norm.al
various times.

shi~

in the count in various places at

It is plain that a developmental cause

is present many times since autopsy reports and sternal
punctures show this to be true.

Roberts shows that the

sequence of events is bone marrow hyperplasia followed
in four days by peripheral effect which is then superimposed by the clinical picture in about three or four
days.

This has been confirmed by many investigators.(105)
Is it, then, an entity, a deficient

res~onse

of

the patient, or a non-specific reaction to a factor of
unusual absolute or relative virulence.

The theory

that bacteremia always precedes agranulocytosis has been
disproved.

That it is not always a bone-marrow

hypoplasia is seen by patients who

~how

a normal appear-

ing marrow with a peripheral agranulocytosis.

Perhaps

a chemotactic as well as a maturation factor is present.
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Perhaps anaphylax,is is more important than is supposed.
Why should a person have a sudden leucopenia a few hours
after taking a drug if he is not hypersensitive to this
chemical so as to have "bone marrow shock" due to a
sudden idiosyncrasy? (39).
It is seen, then, that although several etiological
factors are of great importance, many are only theoretical and many more are entirely unknown.

Perhaps

the variations of individuals are being overlooked too
much in this field.

Some people may be born with weak

or sensitive marrow just as other people may inherit
other deficient functioning organs.

Would this not

explain many of the idiopathic cases?

Beck believes

the primary pathology to be not in the bone marrow but
in the particular organ or tissue that regulates granulopoiesis.

Those with a normal bone marrow lack

chemotactic factors while damaged bone marrow shows a
lack of maturation factors.

CLASSIFICATION
Several classifications have been advanced for
the purpose of clearly defining the various types of
agranulocytosis into a workable diagnostic pattern
either from a clinical or a pathological point of view.
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!""'From the standpoint of a more thorough understanding of
the disease, two classifications are necessary; one from
an etiological angle and one from a clinical view point
as far as the resultant symptoms are concerned.

Inasmuch

as this is a paper of primarily clinical aspects, the
subject will be most thoroughly proposed without unnecessarily cluttering the field with detailed
pathological classifications.
An etiological classification:

1.

Agranulotoxicosis
{a) Caused by such myelotoxins as benzoe, arsenic
and the benzene derivatives.

2.

Agranuloradiations
(a) Caused by such elements as X-Ray, Thorium.-X,
and Radium.

Usually involves erythropoiesis

as well as granulopoiesis.
3.

Agranulosepsis
(a) Caused by bacteria or their toxins.

4.

Agranulocytosis
(a) Of unknown origin, consisting of depression of
bone marrow and subsequent overwhelming of body
in areas by bacterial invasion.
{b) Of unknown origin, with the usual depression
of bone marrow and peripheral blood granulocyt es, but without sepsis.

l?.
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( c) Peripheral granulocytopenia without a depressed
marrow.
5.

A leukemic lymphatic leukemia
Granulocytes disappear from peripheral blood.

6.

Acute infectious diseases
Examples:

mumps, measles, malaria, influenza,

dengue, tuberculosis and lues.
7.

Roseola Infantum
A neutropenice of infancy. (105)
On the other hand, there should also be a classifi-

cation which presents the clinical picture:
1.

Acute agranulocytosis with or without sepsis.
Most common form, sepsis, may complicate, but
the patient may die from prostration before
inauguration of sepsis.

2.

Acute Recurring Agranulocytosis with or without
resulting sepsis.
(a) Differs from acute agranulocytosis in having
two, three or more remissions.

3.

Acute agranulocytosis of unknown cause.

4.

Chronic agranulocytosis of unknown cause.
Another clinical classification which is perhaps

more thoroughly symptomatic is the following:
1.

Fulminating type:-

18.

r-.
{a) Characterized by chill, high fever, necrotizing angina, occasional jaundice, and
album.inuria, extreme leucopenia, and neutropenia.

This usually involves necrosis of

granulopoietic system and is generally fatal.
2.

Sub-acute, prolonged:(a) Tender enlargement of lymph nodes and spleen;
moderate to extreme leucopenia with reduction
of polymorphonuclear neutrophiles.
(b) Usually reddened tender pharynx toward end of
course.
( c) Of one to three weeks duration usually with
recovery.

3.

Recurring or relapsing type.
(a) Three or more attacks, weeks to months apart.
Symptoms similar to either of other two above
types.

4.

Subchronic type.
(a) Leucopenia less intense.
(b) Bone marrow shows more active regeneration.
(c) Usually of one year or more duration with
recovery.

5.

Cyclic type.
(a) Regular, recurring, periodic neutropenia.
These then furnish the reader with a fairly accurate

classification for clinical reasoning.
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. SYMPTOMS .AND COURSE

In considering this phase of the subject, the
discussion will be divided into five parts, namely;
agranulotoxicosis, dealing with the chemical etiological
factors;

agranuloradiation, dealing with X-ray, etc.;

agranulosepic, dealing'with bacteria and their products
as etiology idiopathic agranulocytosis;

and finally,

miscellaneous causes either proven or suspected.

Because

it is the most true clinical type and the first described, the general classification will be based about
agranulocytosis proper; the following four types will
be described only inasmuch as their variations.
Agranulocytosis:
This disease cannot be a specific disease process
and entity because:

(a) there is a marked leucopenia

in several types of infection;
of necrotic foci;

(b) there are a variety

(c) epidemicity has not been reported;

(d) it is not confined to class, age, sex etc.;
is no constant etiological factor;

(e) there

( f) it has not been

satisfactorily reproduced experimentally. ( 50).
The patient presents himself in a very pathetic
state.

He is wilted in appearance and his skin shows

marked palor although the mucous membranes are of
surprisiµgly good color.
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He is weak, sometimes almost

to the point of prostration, with a general toxic
appearance.

Jaundice is sometimes but rather rarely

seen in this condition.
enlarged.
drowsiness.

The liver and spleen may be

He complains of easy fatigue and a constant
He may also state that he seems to be easily

infected with various organisms.
The severity of these symptoms is usually parallel
to the degree of leukopenia.

This is the condition and

stage in which the physician usually sees the patient.
It has been presented first in order that the idea might
be gained as to the probable condition of the patient
when diagnosis is made. (?)
The onset usually occurs in a period of seemingly,
good health, but may follow various chronic conditions.
It is manifested by a sudden rise in temperature, sore
throat, chills and malaise, and perhaps dysphagia,
vomiting, headache, and general aching.

A fetid odor

of the breath is almost always present.

The fever is

from 101' to 106', and of continual type. ( 61)
The previous health may be characterized by lack
of vitality and by weakness, but this is usually not
true.

The patient may also complain of palpitation of

the heart and a murmur may be present. (?)
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At this time an examination of the blood will show
a lowered white blood count with a preponderance of the
lymphocytes and a lowered polymorphonuclear count.
Platelets are usually within normal limits, but in some
types may be reduced.

This will be discussed later. (37}

Coincident with or just following this period,
ulcers of the gums,

palate, uvula, pharynx or

so~

other oral locations usually develop.

This is usually

accompanied by marked edena of the surrounding tissue
and a regional lymphadenopathy.
of sepsis is now present.

A superimposed picture

A membrane, yellowish or

green in color, forms over the ulcers which may be
pulled free rather easily with no evidence of bleeding.
These ulcers may be present on other mucous membrane
surfaces such as the anus and vagina, but this is not
constant. ( 89)
According to Kracke, the blood picture always
precedes the clinical onset, but Green and Fitz-Hugh in
1933 state that it sometimes follows sepsis. (66) (37)
Many of these cases die with bronchial pneumonia. ( 66)
· Most of the above described cases which are the
typical acute variety may die, but some may recover to
become chronic.

In this type· an acute future remission

usually occurs.

In another type the patient may
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completely recover only to suffer another attack at a
later date.

According to its regularity or non-

regularity, this would either be the cyclic or remitting
type.

In these types the blood count never returns to

normal as far as the neutrophilic elements are concerned
but always remains at a low normal.
In the chronic type with no acute attacks, the
observer usually sees a constantly low (from 1,000 3,000) white blood count with a lowered neutrophilic
element.

The only constant symptom is weakness which

is accentuated when the blood count drops. (66)

In these

long continued cases one usually sees monocytes and
endotheliocytes in the peripheral blood.

This is

probably due to an extramedullary response. ( 42)
To bear out the above points, a few clinical cases
might be reviewed briefly.
La Salle reports a case with the typical picture
of an acute type of particular violence.
been feeling ill for a few days
One day he developed a headache.

~~th

Patient had

symptoms of weakness.

Upon the following

day he was very weak with a sore throat; he stayed in
bed with a cough.

A physician was called who diagnosed

the condition, Influenza.

Two days later he was

ad..rn.itted to hospital in a comatose cond.ition.

. 3.

His

throat was very red and his pulse rapid with a low
blood pressure; respirations were 32 per minute.
A red blood count showed 4,300,000; there was a white
blood count of 4,300 with 2% neutrophiles.

The patient

died seven and one-half hours later. {77)
Another case reported with fever, sore throat,
malaise and prostration.

The blood count was low on

the white side with a low percentage of neutrophils.
Treatment was of no benefit; the patient's condition
became worse, his throat ulcerated and he died without
sepsis. ( 103)
A case showed a white blood count of 3,500 six
weeks before his death.

He entered with sore throat,

ulceration, lymph adenopathy, weakness, drowsiness,
malaise.

The white blood count was 160, polys 22%.

The case progressed rapidly and resulted in death. (4)
Another case reported an anal swelling five weeks
before, acute pain in the same region three weeks before,
bleeding from anus and malaise.

Patient was operated

for hemorrhoids and an anal fistula noted.
afterwards he developed an anal ulcer.

Directly

The white blood

count was lowered to 1,700, predominantly lymphocytes.
Clinically he showed malaise, fever, etc.

His white

count went steadily downward until he died. (17)

24.
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Another case with the same typical findings, except
an additional skin necrosis was noted with an accompanying pharyngeal ulcer.

Another case showed circumscribed

ulcers on legs accompanying gum ulcers.

In the latter

case, although the platelets were decreased, no bleeding
was noted. (21)
Marriott reports a typical case with a white blood
count of 900, although the red count remained normal.
The case recovered.

Cannon reports a case with a white

blood count of .400 that recovered. (80) (19)
When we come to the remission type of this entity
we usually have a slightly less acute form, separated
by periods of good health.
A case has been reported in which a patient suffered
sore mouth, fever, malaise, drowsiness, but of a less
acute form and was able to walk about.

His red blood

count was little affected and although his platelets
were decreased, he suffered no hemorrhage.

His white

blood count was lowered and his neutrophils were
reduced.

Between attacks· he was able to carry on his

activities in good health.

Patient is 19 years old

ana still having his attacks. (108)
A case vdlich had three relapses,

each having the

typical acute symptoms and signs, although treated with
X- Ray. died. (42)
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Chronic cases present same symptoms with no
ulcers or extreme prostration.

The blood count is

usually higher and the percentage of neutrophils
generally greater.

Patients have weakness in proportion

to the low white blood count.
Kracke et al, believes that infection actually
stimulates the bone marrow, thus shortening the course
of the disease.

They believe that infection may weaken

and serve to bring on second attacks, which may be
accompanied by nervous symptoms. ( 65)
The next class to be dealt with is agranulosepsis.
Du Bray reports a very typically acute picture of
this disease that had recurring attacks every few months
for a duration of two years.
acute attack.

The patient died in an

The throat was continually positive for

Loefflers bacillus, and he offers the possibility of a
bacterial, bodily balance which would shift one way and
then the other. (33).
Another case was that of a woman who had Herpes
zoster with recovery.

After this she developed a

coronary occlusion with apparent definite improvement.
Later, a pulmonary infarct was contracted.

She was

progressing quite well following this when five days
later, she had a temperature of 100.4. She had both a
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sore rectum and a sore throat.
temperature went up to 105°.

The next day her
Her throat was very

reddened and her blood picture showed a white blood
count of 1200; 100% of which were lymphocytes.

One

injection of neoarsphenamine was given. Her temperature
decreased, but the next day was again up to 105°.

Her

white blood picture showed 550 cells, all lymphocytes.
She died shortly afterwards. (3).
Blumer describes a case with a tooth absoess that
developed a weakness, cough, anorexia, fever, loss of
weight and an enlarged liver.
a marked leucopenia and anemia.
and lobar pneumonia.

The blood picture showed
Death was due to sepsis

The bone marrow showed strangely

mark'ed hyperplasia.
Swartz described a case with perinephritic abscess
who recovered, developed gingiv:tti.s and died with typical
agranulocytosis.
Strusberg describes a case following osteomyelitis
which again showed the typical picture. (12}
Three cases were ·reported by Hard, including two
sisters and one sister-in-law.

All were typical cases.

All showed a positive blood culture of Friedlanders
pneumobacillus.

Hard believes these cases were on an

infectious basis, the location in the blood stream. (4?)
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Huncler pointed out a case following fracture of the
tibia, cellulitis and erythema multifo:rme. (52)
An interesting case was published by Dwyer who
described a boy, age six, with anemia, enlargement of
salivary glands and spleen.

He developed a leukopenia

with complete absence of neutrophils.

There was no

extreme lymphocytic nor myeloid infiltration of organs
as appear in leukemia.

There was no evidence of primary

disturbance of myelogenous marrow at autopsy.

A

streptococcus septicemia was found to be present at
necropsy, which pointed to the infectious agranulocytosis. (34).
Rutledge et al, cite a case of a

2t

year old child

who had attacks of furunculosis every two to three
weeks for six to ten days.

These "attacks" had been

present from early childhood and were accompanied by
gastro-intestinal disturbance, lassitude, drowsiness,
irritability, sore throat, sore mouth, cervical adenitis,
fever of septic type, leucopenia agranulocytosis.
Patient would be ill for four to six days, then
mononucleus and transitional cells would appear and the
case would improve. (108)
Babbit reported a case under his observation for
some period, who developed a sore mouth from which

...;
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Vincent's was cultured; subsequently she developed a
typical agranulocytosis.

The patient recovered under

local treatment supported with blood transfusions and
X-ray of the long bones. (5).
A case cited where a combination of Streptococcus
and Staphylococcus septicemia, together with Vincent's,
seemed to cause the typcial picture of granulopenia. (4?).
All these case reports seem to point out that
agranulocytosis may be etiologically produced by
infection.

The cases were briefly stated and in general

showed the typical picture with one of sepsis imposed,
i.e. septic temperature, etc.
On the other hand, some investigators as Hueper,
O'Connor and Kracke, believe that the infection is
secondary to the lowered blood count.

In reviewing

their cases, they have been able to prove this in most
of them and never have showed the reciprocal to be true.
Probably both happen, since one investigator was able
to produce the picture with bacterial toxins but was
unable to produce the symptoms with the bacterial
cultures.

It seemed from this that probable toxic

etiology was an established fact, but that bacteria
themselves seemed to raise the blood count, as is
generally suspected, and not lower it. (28).
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Agranuloradiation has been described as another
type of the entity.
Although radiation is used as a stimulant to the
bone marrow in the form of X-ray, it is not without
its dangers.

A dose of the radiation Which would

stimulate one person's marrow to hyperplasia, might
definitely impede another.

The exact dosage is,

therefore, uncertain and only very small doses should
be given at the beginning of treatment and these only
by a competent radiologist.
In the same manner doses of radioactive substances
as radium and thorium act.

Thorium used in stimulating

doses causes first an anemia and brief leucopenia which
is followed by a lymphocytosis and a polynucleosis.
The platelet count is reduced and a delay in bleeding
time with poor clot retraction is present
of 5cc injections (2 injections).

a~er

two days

If the dosage is

kept up, a gradual depletion or a complete aplasia of
all elements of the blood is not ed. (113)
Often radioactive substances are deposited in the
spleen, bone marrow and liver from small continuous
doses.

In these cases the first effect is a stimulatory

effect on all blood elements which continues until the
blastic cells are irritated too long; then we get
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destruction and the resulting aplastic anemia.
Thorium and mesothorium and radiothorium are more
active than radium in this manner.
One employee, working from five to six years,
may

ea~ily

have one mg. of radioactive substance

deposited in bone, allowing a liberal amount as
'excreted.

Such a case was admitted to a hospital with

a temperature of 101°- 102° and a pulse of 120/ minute.
His gums contained ulcers.

The laboratory work showed

hemoglobin 33%, red blood count 1,400,000 and white
blood count of 400 with
and 58% lymphocytes.

40%

neutrophils,

2%

histeocytes

There were areas of hemorrhage

and petechial about the body.

The bone marrow was deep

red, resembling pernicious anemia, except that there
were no iron deposits (hemosiderin) and no destruction
of red cells.

The spleen showed atrophic malphegian

corpuscles and diffuse fibrosis.

The peripheral blood

was that or a profound anemia with anisocytosis,
megaloblasts, and a leucopenia.
were positive.

Electrometer tests

The patient ,died. (81).

The reticular endothelial cells of the liver and
spleen show cloudy swelling and macrophages are present.(113)
In this form of poisoning, then, we do not see a
strict agranulocytosis, but rather an associated
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f'agranulocytosis with accompanying anemia and reduction
of other cellular elements including thrombocytes.
Since the granulocytes are affected first, a disease
process resembling agranulocytosis is obtained.
Agranulotoxicoses forms that group of clinical
granulopenias whose etiology is benzol and its derivatives mainly.
Many chemicals which are by some generally thought
to produce this entity are innocent of it.

It would be

well to consider these briefly.
Lead is considered sometimes to be a leucotoxin,
but only affects the red blood count.
Cases reported preceded by arsenic ingestion, but
experimentally a great majority of clinical cases again
show only erythropoiesis to be affected.
Mercury is primarily an effector of red blood cells
as is vanadium.

Phosgene increases leucocytes and

neutrophiles but later a reduction of red cells,
hemoglobin results.

Hydrogen sulphide stimulates

lymphocytes, also the polymorphic elements.
Of course, if one believes in the monophylitic
theory of blood production, it is easy to see how a
primary erythropoietic toxin might in time become a
leucocytic toxin by destroying the stem cells of both

32.

white and red elements.

Likewise, any substance which

stimulates leucoyy'ti'C stem cells may, if' continued long
enough or in high enough doses, injure the cells; so the
clinical reported cases with these substances may be
authentic even if' only one is reported.
The most important chemical poisons to the leucocytic
system are, benzene and its derivatives.
industry is a frequent offend.er.

Benzene in

The symptoms are

ushered in by dizziness, incoordinated movements and
twitching of' muscles which may last for hours.

Bright

red spots of petechial hemorrhage appear on the body;
cynosis is prevalent and there may be massive hemorrhage
from the gastro-intestinal tract.
is generally noted.

A marked weight loss

A hemic murmur may be present.

No

benzene can be demonstrated in the blood, but the phenols
in the blood and urine increase in concentration.

Tne

blood picture shows a leucopenia, a reduced hemoglobin,
an anemia and· a thrombopenia.

The red cells show

anisocytosis and poikilocytosis.

The neutrophils are

reduced, and the mononuclear cells are elevated.

There

may be a complete absence of white blood corpuscles.
A strange factor enters when one finds that recovery is
possible even after almost total aplasia of the bone
marrow. ( 45)
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Amidopyrine usually, if taken in large enough
doses, produces the same results.

Trinitrololuene

produces the same results as do other benzene derivatives.
It has been shown experimentally that benzene is
primarily a leucotoxin.

Most observers think even more

specifically and designate the neutrophiles.

Thus

clinically many of the benzene derivatives may cause
almost typical agranulocytic angina.

A few clinical

cases might be briefly mentioned.
Kracke mentioned a case that took several benzene
derivatives for three years before an attack of agranulocytic angina.

The attack was accompanied by

methem.oglobinemia which further points to the etiology
of benzene. (67).
One patient took over ten gallons of elixir of
phenobarbital in five years together with luminol,
when she woke up at night.

gr~

She developed a severe anemia,

a white blood picture of 1, 500 with a low neutrophile
percent.

Although these never completely disappeared,

the patient recovered. ( 54)
Another patient was a heavy user of aspirin for
several years.

This person showed a typical agranu-

locytosis with a low white blood count (470), with low
percentage of neutrophiles.
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The patient recovered from

this attack but later died in a second attack after
extraction of some teeth. (86).
Berg and Holtzman report a case that took 5 gr.
of amidopyrine every 4 hours for five days and developed
fever, cramps and nausea.

The medicine was discontinued

for four days and the symptoms were alleviated.

Then

she took one tablet after meals f.or seven days and the
symptoms returned.

After she again felt well, two tablets

a day were taken for eleven days following which nausea,
vomiting, fever of 104°, prostration and abdominal pain
developed.

The next morning the temperature was 107°;

a marked leucopenia was noted in which no neutrophils
were seen.

The larynx becameedematous

days, ulcers of pharynx developed.

and

a~er

three

The patient died. (11).

A patient entered a. hospital with a history of
ingestion of three tablets of Causalin (equal parts
hydroquinoline and.amidopyrine) a day for one month.
A week before, a sore throat and a fever developed.
She had a white blood picture of 1,200 of which only

4% were neutrophiles; the red blood p·icture was also
reduoed to

3,300,000~

The patient died.

Another patient took 200 tablets of the same drug
in three weeks.

On the eleventh day she developed ulcer

of the tongue, chills and a fever.
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At the end of three

I""'weeks her white blood picture showed 1,600, 63%
lymphocytes, 35% monocytes, 2% basophiles and no
neutrophiles.

The red blood count was reduced to

3,830,000 and
The patient recovered. (55).
Fitz-Hugh states that am.idopyrine is an important
factor but will not cause agranulocytosis by itself,
as it needs an idiosyncrasy to enhance its action.
There is no way of telling which patient will show this
idiosyncrasy.

Patch tests frequently show sensitivity

to am.idopyrine.

Once established, the patient usually

dies with this poisoning. (39).
Sulphanilamide was given to an old syphilitic
patient, 5 gr. for two days, 3.75 grs. for three days,
2 grs for 13 days.

On the fifteenth day, the white blood

picture was 3, 900, tb.e red blood count was 4, 170, 000.
After eighteen days, the white blood picture showed
2,000 cells., 100% lymphocytes.
throat developed.

A high fever and a sore

The patient died.

Edema of larynx,

edema of Kupfercells of liver, atrophy of splenic
malphigian bodies, marrow depleted of polys, stem cell
hyperplasia and reduction, degeneration of nucleated
reds were seen at autopsy. (109).

_________________________
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Another patient received 110 gr. of sulphanilamide
in treatment of a Bartholine abscess.

He received in

seventeen days, two 15 gr. doses, and after first dose
felt dizzy, drowsy, headache, nauseated and his heart
showed palpitation.

The white blood picture showed

1?, 500, 8?% of which were polys.
normal.

The red count was

Two more days passed in which 80 grs. of drug

were given.

The red blood count dropped to 3,960,000

and the white blood count to 2,900 with 64% neutrophiles.
Nine days later no neutrophils in blood.

The drug was

stopped and the patient returned to normal. (1)
Sulphanilamide was given to another patient at the
rate of 15 grs. per day for thirty days.

The patient

developed typical neutropenia with white blood count of
450 and no neutrophiles.
patient recovered.

A~er

ceasing the drug, the

Sulphanilamide at

?i

grs. per day was

given with a rapid fall in white blood picture and
neutrophiles being noted. (8?).
Neoarsphenamin upon its first dose caused fever
and chills in a patient.
caused nausea, vomiting
weeks duration.
continued.

After one year's treatment it
a.~d

pain in abdomen of three

Later bismuth and neoarsphenamin were

Forty eight hours after the last injection

chills, fever, malaise were noted.

3?.

Platelets count was

84,000; the white blood picture showed 2,000 with
1/3-1/2 of them neutrophils.

The patient recovered in

four days after stopping the treatment. (10).
A case showed typical agranulocytosis.

After two

weeks treatment with silver salvarsan, the patient
recovered after cessation of treatment. (82).
Thus it seems that both benzene and its derivatives
react the same or practically the same on man.
A few other myelotoxins may be mentioned briefly
by citing a few cases as examples.

Two doses of sodium

theosulphate of 40 mg. in injections were given one week
apart.

A night following the second dose the patient

developed a typical agranulocytic angina as far as the
blood picture was concerned.
symptoms were ushered in.

The next day clinical

The patient recovered with K 96

treatment in ten days. ( 101).
In a case of cerebral injury, potassium. arsenite
was given for 36 days, starting at 6 minims and building
dose to 39 minims daily.

Phenobarbi tol was given at the

rate of gr.1 ;s

The white blood picture decreased

per day.

from 14,000 to 1,300 with a decrease in neutrophiles from
62 to

~.

Recovery followed in two weeks after cessation

of treatment. ( 125)
Another case (developed after a case of mercurial
injection) which was quite typical except for a profound

anemia, and· thrombocytopenia with purpura.

Typical

agranulocytic symptoms prevailed, since the anemia
secondary to thrombopenia, as shown by marrow which was
aplastic for granulocytic elements but hyperplastic for
erythrocytic elements.

The case died. {35).

Thus it is seen that the chemical myelotoxins do
not strictly hold to the granulocytes, but can and
usually do, incorporate destruction of other blood
elements with the production of the symptoms typical of
depletion of these same elements.
Miscellaneous types:-In other blood dyscrasias such as lymphatic leukemias,
etc., the myelogenous elements may be "crowded out";
so that neutrophiles are not developed or are greatly
in minority.

Symptoms of agranulocytic angina usually

are superimposed by the symptoms of the other disease.(27)
Added insulting of the system with bacterial or
other toxins may produce the typical picture.

Cases of

carcinoma and other debilitating diseases have been
complicated with this picture of agranulocytic angina,
probably also from toxic effects on bone marrow of the
luberated toxins.
Call reports a case of an eight months pregnant
woman who developed abdominal pain, tremor, fever,
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rigors, laryngitis, throat ulcers and a temperature.
The white blood picture was low, with a low percentage
of neutrophils and a low red blood picture.

The mucous

membrane of the rectum, vagina and vulva was swollen and
red.

Typical agranulocytosis resulted. (18).
Other etiological factors such as fatigue, sleep-

lessness, worry, etc., are accredited with causing the
typical picture.
It is seen, then, that regardless whether or not
the etiological agent is known, the basic synchrone is
very similar.
As additional elements, variations such as anemic
symptoms of benzol poisoning or the hemorrhage signs of
the same or the septic symptoms of agranulosepsis may
occur.
"EXPERIMENT AL WORK

This section will not be inclusive of this work,
but will only deal with that portion of clinical
experimental work or animal experimentation which directly
bears out some clinical point or seems to disprove some
clinical conception which
· sections of this thesis.

ha~

been mentioned in previous

The animal experimental points

therefore, will be mentioned very briefly since this is

,.....__
'

primarily a clinical thesis.

.
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Dr. Plum had treated a patient with 20 grains of
amidopyrine (who had suffered from agranulocytosis several
years previously). The patient developed chills and fever
and was indisposed one hour after injection.

His

sedimintation rate decreased in five days from 28 mm.
)

per hour to 10 mm.
The white blood picture dropped from 9,000 to
1,500 in one hour and one half.

In double that time

it had climbed to 11,500, then slowly down to 2,000 in
24 hours.

It then climbed to 10,400 in eight days and

leveled off gradually.

Granulocytes dropped from 5,700

to 1,450 in one and one half hours.

Twenty four hours

later the count decreased to 1,150 and remained in this
neighborhood for ten days, after which it returned to
normal.

There was a marked shift to the left in these

elements; the non-granular elements had a primary fall
in the first hour to 150, then gradually climbed to
normal in ten days. (95).
From this it may be seen that drugs undoubtedly do
produce the entity, and also that the more primitive
cells, the lymphocytes, are greatly affected.

Since

here is a disturbance of potential stem cells, one may
gather how serious and persistant the leucopenia may
become.
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Harris and Schattenberg extracted the toxins
from cultures of bacteria which were isolated from
stools of

a~

agranulocytic patient.

Animals injected

with this toxin produced a low white blood count,
predominately of a lowered neutrophil type.

Injections

of bacterial cultures showed a raised count.

Different

organisms producing this effect were B. enteritidis,
Streptococcus, hemolyticus, staphlococcus aureus, B.
typhosis, and B. welchii. (46}
In another experiment, bacteria from focal infections
of patients were cultured.
Staphlococci and
peritoneally.

These cultures, mostly

~treptococci

were inplanted intra-

They produced a leucopenia, some acute,

but only the granulopoietic elements were affected, the
mononuclears remaining constant.

Controls were

negativ~.

Cultures injected caused a leucocytosis.
These experiments showed that toxic products of
bacteria may have a similar effect, but that bacteria
themselves do not. (28).
Benzol experiments in general bear out clinical
experiments in that an agranulocytosis is produced and
also a depletion of red elements; occasionally various
other or all of the other elements may be depressed such
as:

the thrombocytes, lymphocytes, etc.
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Many clinical

(.,-,..,
symptoms may also be noted in these animals such as
loss of weight, malaise, anorexia, oral ulcers, bone
marrow, spleen and lymphatic tissue changes, etc.
The same can be said in general for the products of
benzene, amidopyrine, acetaphede, trinitrololuene, and
other benzene ring products.

Perhaps it is of interest

that benzol products with an amino group attached to
the ring seem more
not.

o~en

offenders than those that are

Selling explains this by saying that these are the

ones most easily oxidized to toxic products such as
phenol and catechol, etc.

He attempts to prove this by

showing increased excretion of phenol

a~er

benzene and

an increased amount of phenol in body tissues.

Nowhere

could he demonstrate benzene, except at site of injection.
This clinical paper is not to be laden with further
indirect experimental evidence, since it can never be
directly applied to the clinical case, but will refer
the reader to articles of this nature, should he desire
to acquaint himself with this part of the work. (110),
(118), (113), (82), (78), {102), (13), (97), (23), (53)

( 91) , ( 20) ' ( 120) '

( 121) , ( 12 2) '

( 12 3) '

( 124) •

PATHOLOGICAL .ANATOMY
In writing the section on pathology, it is well to
oover a few physiological points and to deal with the
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r-pathological state more as a physiological mechanism
since it is only in this manner that effects can be
visualized.
The granulopoietic system is located in the red
bone marrow which is found in the ribs, the vertebrae,
the sternum, the bones of the skull and as innominatum.
·It is in the red marrow that granulopoesis takes place
normally.

The size of the granulopoietic organ in the

adult has a volume of about 1,420 cc, which is thirteen
times as great as that of the spleen and about the same
as that of the liver.

There are from three to twenty

times as much tissue devoted to granulopoiesis as there
is to erythropoiesis.

The life span of the neutrophil

is about four days after it reaches the blood stream.
There are various physiological outflowings of the
granulocytes from the blood into the tissues with
consumption in the tissues.

Neutrophils are eliminated

into the saliva, the entire digestive tract, e.nd through
all the mucous membranes.

A gradual loss of granu-

lopoietic tissue ensues with advancing years. (7).
The granulocytes have an hourly fluctuation.

There is

a reciprocal relationship between myelocytes and the
mature neutrophiles.

It is suggested, then, that this

fluctuation is caused by withdrawal of the mature
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neutrophiles from the peripheral circulation. (30).
Besides this hourly fluctuation, there are two general
tides of leucocytes.
aft~rnoon

The tide is high in the early

and in the hours after midnight.

This is

largely due to the neutrophilic element and is not
influenced by any factor of daily life.
individual variation in this process.

There is little
The fluctuation

is not confined to the periphery, but is generalized
over the entire body. (111).

Sabin showed rhythmic

occurrence of young polymorphs in the periphery after
occurrence of old non-motal neutrophiles.

This may account

for the occurrence of an hourly tide, probably by reflex
stimulation.

This further substantiated by the fact

that the blood during these tides shows a neutrophilic
shift to the left. ( 29).
In neutropenia a cessation of the bone marrow supply
of neutrophiles results in a peripheral shortage in about
three to four days.

This may proceed gradually until

the total peripheral count is 1, 000 or less.

At the

beginning of the disease the granulocytes fall rapidly, .
usually to 700 or 600 cmm.

Thus the granulocyte shows

30 to 40% of the total count in chronic cases to absolute
absence in severe forms.
morphology is normal.

In almost all cases their

However, it is found that the
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motility, vitality, and phagocytic ability or the cells
is decreased.

It is interesting to note that besides

the absent maturation factor which would plainly call
forth these changes, there is, many times, a normal or
hyperplastic

gra~ulopoiesis

which also suggests a

chemotactic factor. ( 7) •
Besides the change in neut rophiles there may be a
small to great absolute decrease in the lymphocytes.
This may be without evidence of destruction in the
lymphatic tissues.

A depression of the reticular

endothelial system may cause a decrease in ntnnber of
monocytes.

To compensate for this the macrophages may

be increased, and many times these and the clasmatocytes
elaborate granules and seemingly take over the function
of the granulocyte.
The erythrocyte is usually not decreased except in
chronic cases.

Here the hemoglobin is also effected.

Likewise, in long cases, the blood platelets may show a
reduction. (7).

In contradistinction to the latter

statement, Danashek, in a review of many cases, states
that thrombocytes are decreased only in the first two
weeks.

Most investigators hold that this is not true

and that if a change in thrombocyt es is noted in the
first two weeks, it is an increase rather than a
decrease. ( 25) •
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It must be remembered that the drop in leucocytes
occurs before the clinical onset is evident, and that
the observer usually sees these changes at completion
of his examination of the clinical case. (6).
At the depth of the disease, a
myelocytes can be observed.

shi~

to the

le~

of

It has been suggested that

there are not only young cells but abnormal young cells
which might further suggest an abnormal chemotactic
factor as well as the maturation factor.

This phenomena

is o:ften seen in cases with hyperplasia of the marrow.(38)·
It is sometimes confusing to see the generality o:f
this description confused by infection.
changes the entire picture.

Many times this

Here if the observer will

merely consider the effects of this process and the initial
cells which it has to effect in the blood, he can
interpret the changes. (65)
The toxicity of the blood serum itself has been
suggested by several observers.

Beck mixed normal

leucocytes with serum of a patient suffering from
agranulocytosis.

The leucocytes were seen to become

rounded and lose their mortality in about 45 minutes.(7)
It might be interesting here to consider a theory
of antigen and its reactivity which has long been
suggested. by clinical observers.

,,....._
.

Shiff found that by

inje.cting benzene, an etiological factor of this disease,
'
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intraperitoneally in animals, the reactivity of antigen
was increased.

Rush found that rabbits injected with

this substance reduce lysin formation for sheep blood
corpuscles and praecipitin for horse serum in the conditioned rabbit.

Simmonds and Jones found a reduction

of lysins for dog corpuscles and for typhoid apsonin in
cohditioned rabbits (114).

Winternitz found same to be

true for pneum.ococcus. (?).

Hektoen repeated this work

and stated that at high antibody production benzene has
little effect on leucocytes and also that it lowered
leucocytic activity. (49).
This then points out that benzene may effect the
white cells in another indirect way.
In acute fulminating cases of idiopathic nature,
the pathology is usually limited to the marrow of the
long bones.
lopoiesis.

Here is seen usually a hypoplastic granuThe erythroblastic elements are usually

unaffected. (65).

The bone marrow changes are the same

in the living patient as in the necropsy specimen.
has been shown by sternal biopsys. (61).

This

The bone marrow

in fatal cases usually shows marked degeneration.

The

marrow shows patchy necrosis, with the myelooytes and
neutrophiles absent, or nearly so.

The megakaryocytes

and no:nnoblasts are usually uneffected so that the
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hypoplasia involves the granulocytes only.

However,

this is not always true since three distinct types have
been noticed; in one, a maturation of myelocytes had
ceased; in another type, there was myeloid aplasia; while
a third type showed normal myeloid elements. (7).
The myelocytes themselves are usually degenerative or
necrotic.

Some cells have deeply basophic and vacuolated

cytoplasm with large pale staining nuclei.
several nuclei.

Some contain

Rose and Houser saw hyalin drops in

the cytoplasm with pale falloned or picnotic nuclei.
Ven der Wielen describes cells with no granulation and
small picnotic nuclei.

Offenorde spoke of large cells

with a pale cytoplasm and various forms of nuclear
degeneration.

Fried, Danashek, Naegele and Koch spoke

of wide necrosis of the marrow.
bone marrow was

o~en

Koch added that the

deprived of granulopoietic elements

but that lymphoblastic elements were greatly increased.
The reticuloendothelial elements are

o~en

hypertrophic

and show erythrophagocytosis and phagocytosis of iron
pigment.

Perchenbach's patient showed a fatty bone

marrow with cellular areas composed chiefly of promyelocytes.

Fitz-Hugh and Krumbhaar found that many times

the mature granulocytes are absent and that there is an

,...._

abnormal nmnber of young neylocytes with pale nuclei
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and many neutrophllic granules.

Many times death may

occur when'there is an abundance of these parental cells
but a peripheral leucopenia.
is de:ficient at work.

Here the maturation factor

Zekowsky believed that in hyper-

plastic marrows a bloch (chemotactic factor) existed.
If this held for a period of time, degeneration would
begin.

Many cases at death show myeloid hyperplasia.

Following are a few concrete examples of some of
these cases:
In three cases of idiopathic agranulocytosis the
bone marrow was found to be much more cellular than the
age of the patient would suggest.

In this hyperplasia

the granulopoietic tissue of the patient took an active
part.

It seems, tllerefore, that in some cases the

agranulocytic catastrophe is preceded by a proliferation
of the young myelocytes.

In some cases, the cell content

· of the bone marrow of the femur was not increased, and
the destruction of the granulopoietic tissue did not
follow an initial hyperplasia.

In both the hyperplastic

and the non-hyperplastic bone marrow, the granulopoietic
cells revealed severe regressive changes, and it was
often only by comparison

with the less altered cells

that the young myelocytes could be identified as such.
Specific granulation is the first to become affected
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while the nucleus remains intact for some time and may
even divide by mitosis.

Specific granules swell, their

outlines become indistinct, and small vacuoles often
appear around them.

The granules later dissolve into

these vacuoles and pale purple pink: droplets result,
which fuse together, giving a vacuolated appearance to
the cells.

In the meantime, the chromatin o:f the nuclei

has become separated into coarse, sharply defined clumps,
and the nuclei have disappeared.

An occasional mitosis

may be detected in a cell which has been deprived of its
granulation.

The mitosis is, however, a typical with

short and clumsy chromosomes and do not seem to pass
beyond the metaphase.

The nucleus finally shrinks and

disappears; the cytoplasm coagulates and the cell dies.
With the dissolution of the granules into the vacuoles
the oxidase reaction becomes negative.

When present,

the myeloblasts appear intae.t which suggests that
therapeutic attempts are not absolutely hopeless in the
acute forms of the disease.
The great majority of cases of agranulocytosis show
histological evidences of a severe injury to the granulopoiet ic tissue.
In many cases, the giant .cells are increased in
number and many young f'orm.s with signs o:f multiplication
of the nuclei were present. Thus the megokaryocytes may
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may be involved also.
In cases of long standing granulopenia, a moderate
anemia may develop.

The norm.oblasts vary considerably

in size, and some of them were large and hyperchronic.
Segment at ion of the nucleus infrequently seen before
picknosis is complete.
Lymphocytes and plasma cells are always present (59(.
The liver shows perivascular lymphocytic infiltration;
Kupfer cells containing much pigment and Glisson's
capsule is

o~en

exudate. (94).

l''"""

present.

overlain with a thin inflammatory

An increase in Kupfer's cells is o~en

The liver cells themselves show cloudy swelling

and small areas of necrosis. (?).
The spleen often shows tremendous development of
the reticular endothelial system at the expense of the
lymphatic elements.

The sinus are empty, with the

exception of a few lymphocytes, plasma cells, and red
blood corpuscles.

The reticulum of the white pulp

contains scattered lymph and plasma cells.
are present. (94).

Megakaryocytes

The whole organ might be enlarged

due to the reticuloendothelial hypertrophy.

No young

cells or lymphoblasts are seen in the atrophic lymph
follicles, but only mature lymphocytes.
are occasionaly seen.
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Anemic infarcts

The lymph nodes are sometimes enlarged with
hemorrhages.

Atrophy of follicles is present with no

young lymphocytes in the germinal center.

A prolif-

eration of reticular endothelial cells is also seen
here. (?).
In the kidney, in cases with sepsis, cloudy swelling
bacterial embolin, marked degeneration of tubules and
acute nephitis is seen. (94).
Necrotic lesions of the mouth, anus and cervix show
an absence of a surrounding inflammatory zone, no granulocytes being present.

O~en

edema and gangrene are seen.

The gastro-intestinal tract may also present ulcerations.
The lung shows sub-pleural hemorrhages with bacteria.
Complications by generalized infection, toxic myocarditis,
cloudy swelling, fatty degeneration and multiple areas
of necrosis of' the liver may be encountered. ('65).

These

ulcerative sites are secondary to blood changes and due
to lack of body resistance. (61).
The pathological changes in septic forms has already
been mentioned and shown how it might change and complicate the picture both in hematological and local
pathology.
Changes due to radiation or to drug influence are
essentially the same as described above.

The differences

are merely that the red elements and negakaryocytes seem
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to be more prone to changes than in the idiopathic form.
These changes are however, the same as those listed
above as far as clinical facilities can be determined
but tend to advance with the granulopenia rather than
only in old chronic cases as it was described under in
the above discertation.

However, even here, granulopenia

and effect on granulopoiesis is much more marked.
These points are born out by experimental production
on laboratory animals, and by accidental poisoning in
clinical cases. (32), (90), (69), (88), (113).

DIAGNOSIS .AND DIFFERENTIAL DIAGNOSIS
This is usually rather simply made if one observes
all of the material with which he has to work.

Beck

states that if one has the clinical picture, accompanied
with a persistent ulcerative lesion, a study of the
blood picture, with perhaps a sternal biopsy, will cinch
tbe diagnosis. (?).

A clinical syndrome might be de-

scribed as: (a) weakness, (b) easy exhaustion, (c) tendency
to fatigue, {d) loss of strength and inertia, (e) a loss
in the number of granulocytes.

The severity of the

disease almost parallels the degree of depletion of
the bone marrow elements.
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A few entities might be confused with this picture.
Ludwig's angina differs in that the membrane of agranulocytosis is a tenacious gray membrane which does not
bleed on removal.

This also is easily ruled out by

the blood picture.

Some investigators class thorium.,

arsenic, benzol and x-ray as acute poisons with secondary granulopenia.
by history.

Differential diagnosis is made here

X-ray also first attacks the lymphocytes

and the granulocytes secondarily.

Acute leukemia

presents a high fever, a mucous membrane with petechial
hemorrhages, enlarged nodes and spleen and a stomatidis
with a leucocytosis.

Sepsis also shows a leucocytosis.

An aleukemic leukemia presents abnormal lymph forms,
presence of polymorphonuclears and the same clinical
picture as leukemia. (61)

A lymphosarcoma may cause

a leucopenia but may be differentiated by clinical
course and biopsy findings.

Aplastic anemia shows a

reduction of all blood elements.
nucleosis will show an increase in

Infectious monocircula~ing

neutrophiles

upon the injection of foreign protein.

THERAPY .AND PROGNOSIS
Discussion of this phase of the subject will
necessarily be laden with many procedures that have
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been proven to be of little value.
true,

indicatio~

If the latter is

will be given af'ter the discussion.

Local lesions are present in the form of ulcers
of the. various mucous membranes.

The most important

are found in the oral and pharyngeal cavities.

These

are primarily treated by cleanliness subsidized by
application of antiseptic solutions. (65)
treatment can be outlined as follows:

A method of

A saturated

solution of potassium chlorate is sprayed on the
cleansed lesion.

The denuded area is then painted with

a solution of ten grains of copper sulphate per ounce
of water.

The phlegm.onous masses are then excised and

any abscesses are drained.

It is well to mention here

that surgical procedures should be avoided unless
absolutely necessary since the lowered concentration of
white blood cells make it a dangerous enterprise. (7)
Nucleic acid and its derivatives were probably the
most important development ever advised with the possible
exception .of the yellow bone marrow extract recently
advocated.

Nucleotides were first advocated in 1897

by .Ames, Delano and Huntley, as a treatment for
leucopenia.

They claimed a rise of the white blood

cells in five to ten minutes af'ter injection of the
·{Ilaterial in both the peripheral and central circulation.
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They stated that the polymorphonuclears were little
effected, but that many young mononuclears were present.
In normal patients white blood count could be raised
to 25,000 in forty-five minutes. (2).

It is interesting

to note that even before this experimental work was
done in 1897, Vaughan, who had evidently noted some of
its action upon patients, recommended its use in 1893
as a germicide when given intravenously. (11?).

The

treatment was used intermittently in therapy of
leucopenia with no advancement being made in either its
use or its understanding until 1924 when Jackson
isolated from human blood a substance which he believed
to be adenine nucleotide.

This was combined, or mixed,

wlth an equal amount of pyramidine nucleotide. (56).
In 1925 Jones and Perkins prepared B. Nucleoprotein and
from this fonned crude nucleotides.

They then separated

guanine and adenine fractions and finally obtained the
brucine salt from the pancreas. (60)
suggested the following treatment:

In 1931 Reznikoff
Adenine sulphate

injected at the rate of 0.5 grams in 25cc of normal
saline per day.

In six hours he noticed a rise in the

white blood cells, the polymorphs appearing normal.
He treated two cases ·this way and both recovered. {100)
Dameshek, in a review of this work, stated that this
tnerapy alone had lowered the mortality rate of
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granulopenia from 80-90% to 25%.

He also published

some of his own case work and gave three cases, all of
the relapsing or recurrent type, which had recovered
under use of these derivatives.

To case I he gave 10 cc

of pentnucleotide intramuscularly daily for four days.
After 72 hours from the time the first injection was
given, the white blood count began a gradual climb
which ended five days later with a count of 16,800.
It then gradually returned to normal, remaining thus.
Case II was given adenine sulphate.

One injection of

0.5 grams of material caused definite improvement.

The

leucopenia recurred and was treated with pentnucleotide
with essentially the same results as obtained in case I.
His third case was also treated with pentnucleotides
which showed definite improvement in 72 hours. (24)
Fitz-Hugh injected 0.7 grams of the substance intramuscularly twice daily for four days.

This caused

definite improvement in two days after cessation of
injection.

Granulocytes were seen here for the first

time in two weeks. (37).

Marriott, in one instance,

gave 2.8 grams ( of pentose nucleotide) intramuscularly,
for ten days and then 0.7 grams via the same method for
five days.
liver.

Transfusions were also given along with calf

The patient recovered. (80)
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Adenine sulphate usually produces a speedier improvement in patients but also gives a more severe reaction,
(i.e. chills, etc.) than does pentnucleotide.

If the

leucopenia is secondary to sepsis, aplastic anemia, or
aleukemic leukemia, there will be no improvement.
Following the administration of these drugs, there occurs
a sharp dyspnoea, precordial distress, bradycardia, and
sweating if it is given intravenously.

The latter is not

so marked if the drug is given intramuscularly.

Follow-

ing injection these symptoms usually last for about one
hour.

The first change in the blood picture is histeo-

monocytosis followed by an increase in immature granulocyt es and a rise in the entire white blood count.
The order of appearance of the granular cells is first
myelocytes, metamyelocytes and finally mature neutrophiles.
The white blood count rises about two days after the
appearance of the immature cells.

Clinical improvement

which is coincident with quite a noticeable rise in the
white blood elements, does not occur until five to seven
days.

The counts rise to 18,000 - 20,000, on the

average, after ten days of treatment.

Some investi-

gators found improvement in three or four days, a.fter
injections were started, until clinical improvement was
noticed. ( 24), ( 40).

~-
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From this it is seen that nucleii acid and its
derivatives are primarily chemotactic.

If maturation

is absent, chemotaxis would be of little value; so it
is not the utopia of therapy. (?).

Chemically, nucleic

acid yields, upon hydrolysis, phosphoric acid, a. sugar
or a derivative of a sugar, basis of purine or
pyramidine.

The plant, nucleic acid, has an extra

sugar (d-rebose), and animal nucleic acid has thymine
and desorypentose.

In the digestion of nucleic acid,

it is found that neither the gastric nor pancreatic
enzymes play much of a part.

The succus entericus,

however, contains a nucleinase that converts tetranucleotides to mononucleotides.

It also contains a

nucleinase, n.ucleotidase, nucleosidase; so the end
products as phosphoric acid, nucleosides, sugar, guanine
and adenine go to the liver.

These facts might be

use1Ul as a factor in administrating these products
orally or in administrating animal products rich in
t etranucleotides. ( 44)
A few experimental phases of this form of treatment
might be mentioned.

'l'he induction of nucleinate on

rabbits produces a primary leucopenia for several hours.
This is followed by an increased delivery of new forms
causing leucemia.

Both are due to the granulocytes.
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Bone m.arrow slides show a speeding up of later stages
of granulocyte production.

The primary leucopenia is

caused mostly by the spleen since splenectomy shortens
the primary leucopenia greatly.

The spleen actually

increases in size during the leucopenic period.

Adenine

and guanine sulphate cause no initial leucopenia. (29)
When nucleic acid and its derivatives are injected intravenously with phosphate buffers, a short primary
leucopenia is noted.

This was not produced when normal

saline solution was substituted for the buffer solution.
The leucopenia was caused.by decrease in lymphocytes.
Nucleoproteins also produce a leucopenia. (99)

Climenko

found that nucleic acid and its derivatives do not react
when given

a~er

or with benzol derivatives. (22}

Doan kept animals on nucleinate for 102 to 116 days with
a constant hyperplasia of marrow but found no harm done
to this organ

a~er

this length of time; so this therapy

seems to be quite safe. (31)
Transfusions have been used quite extensively with
this disease but with very doubtful beneficial results.
It is evident that frequent transfusions of a large
enough quantity might serve in keeping a much distressed
patient alive until some more potent form of' therapy may
'""'-··----- --·

be tried.

Fisher used immune serum. from a donor who
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had recovered from granulopenia.

Ordinary blood had

previously been tried with negative results.

After

this transfusion the :patient seemed materially aided,
and he recovered. ( 36)

It seems that such a procedure

would be rather trying, hov-.rever, since the donor was
none too sure of not needing all of his own blood in
a remission.
Radiation of bones with X-ray seems to be definitely
beneficial.
uals.

The exact dose varies greatly with individ-

One-twentieth of a skin unit might be satisfactory

for one individual but quite insufficient for another.
Too large a dose of this material is definitely dangerous, since the very disease one is trying to cure may
be listed as being cau$ed by excessive X-ray as a
etiological agent.

Small doses should be administered

first and only then by a

competent roentgenologist.(7)

Many clinical cases may be found which when this treatment was used, had very definite improvement, both
hematologically and clinically.
Calcium gluconate has been reported as giving a
granulocytic response five days after injections were
started. (7).

Orange juice, brewers yeast, bone marrow

extract and cod liver oil have all been used with
dubious results.

Other miscellaneous items that have
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been tried include milk, gentian violet, fetal liver,
Squibb's leucocytic extract, Armour's extract of spleen,
intravenous antistreptococcus serum, diphtheria antitoxin, non-specific proteins, etc.,

All of these

produced little, if any, effect upon the patient, either
clinically or hemotologi·cally. ( 65)
One investigator used typhoid vaccine with a report
of recovery. (6)

Some cases show an "allergic state"

in which they tremble, etc.

This is especially mani-

fested at the onset of clinical symptoms.
seems to combat this state. ( 39).

Adrenalin
'

Massive doses of

liver therapy, have been used with no definite results.
In cases where symptomatic cardiac discomfort is
developed colloidal sulphur seems to be of some value.(65)
In cases produced by arsphenamine therapy, intravenous
sodium theosulphate seems to present therapeutic
advantages.

The dosage suggested being O. 3 grams,

increasing 0.15 grams daily until 2 grams have been given.
Prophylactic treatment includes rest, cessation of all
types of toxins, and a high vitamin ·B. diet. (?)
There are three types of treatment that are rather
late developments which have been left purposely to the
last for discussion.
clinical data.

For two of these there is no

The first of these substances is
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glutathione.

This is found normally in all body cells.

In cases of benzol poisoning, it is reduced.

In myloid

leukemia, it is especially elevated and in leucopenia
it is decreased.

It was reasoned, therefore, that if

this substance be given, an increase in division of
myelocytes may be obtained.

It is found that beneficial

results are obtained in animals with benzol poisoning,
a leucopenia being present in these same animals.

In

normal animals, however, no leucocytic response was
gained. (92).
Greer, in working with rats with experimental
granulopenia resulting from benzol poisoning, introduced another form of therapy.
spleen.

This was fetal calf

In animals treated, a 25% mortality rate was

established.
was obtained.

In those untreated, 66% mortality rate
In his experiments he found fetal spleen

nucleoprotein, raw fetal spleen and fetal spleen powder
to be ascending in that order in benefit derived.
Pentnucleotid also increased the white blood count,
but a higher mortality rate was noted.

Powdered beef

spleen and fetal spleen cystosine groups were no better
off than the control group.
The third of this last group is a development of
the last year which gives more promise than any treatment
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developed to date.

This is extract of yellow bone

marrow introduced byMarberg and Wiles in 1938.

Yellow

bone marrow was saponified with an excess of potassitnn
hydroxide.

The unsaponif'iable portion was then extracted

in vacuum.

This portion was found to contain almost all

of the active ingredient by clinical tests.

The oil

extracted was then absorbed in some bland oil, such as
cotton seed oil, so that 0.05 cc contained 2 grams of
the strained yellow bone marrow.
tested only one responded.

Of the normal persons

The blood count in this

instance (after one teaspoonful taken orally of the
concentrate) was raised from ?,000 to 21,000 in twenty
four hours.

One case was given 10 drops three times

daily for two days followed by half that dosage.

The

white blood picture went from 2,600 to 5,400 and the
polymorphonuclears from 2?% to 35% in nine days.

Another

patient had been on pentnucleotides but the treatment
was considered unsatisfactory.

With the blood count at

4,500, the patient was given 105 drops of oil per day.
In four days the count was up to 7, 500.

The treatment

was discontinued and the count dropped to 3,500 in four
days.

Then starting with 65 drops per day, it resulted

in a count of 7,500 in five days.

Of seventeen cases

treated, almost all of whom had been treated unsuccessfully with other known forms of treatment, mostly
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nucleotides, ten recovered and seven died.

Of the

seven who died, three had aplastic anemia and one had
diabetes.

Of the ten who recovered, six had agranu-

locytic angina and four had leucopenia without angina.
The response was both clinical and hematological in
forty-eight hours.

The authors state that clinical

recovery followed immediately the return of the blood
picture to the phase expected by the local lesions. ( 79)
The prognosis has been discussed with the types
of treatment.

Here may be given a few generalities.

The prognosis depends upon the severity of the neutropenia.

Rosenthal states that a white blood below 1000

cells per cm. gives a poor prognosis, while one over
1,000 gives a good prognosis.

It must never be for-

gotten, however, that the individual might die from a
subsequent attack. (66).

A mononucleosis developing

in the course of treatment is a favorable sign. (100)
"When the disease was first described, the prognosis
was practically 100% mortality.
90 - 95%.

In 1927 it was still

In 1931 it dropped to 50%, and at the present

time is only 25%.

From this, it is seen that treatment

has not been without its effect.
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rDI SCTJSSION AND SUMI\11.ARY

From the body and discussion of the subject, one
can see that there are still contraversial points.
Most of these are not, however, antagonistic points of
a true nature but merely isolated facts about which the
intermediate is still obscure or not yet worked out.
The history of the disease reveals the fact that
while the recognition of the syndrome itself is only
seventeen years of age, the picture has been described,
sometimes quite completely, all through this century
and had been suggested in the fifty years preceding
.~.

1900.

In the last ten years knowledge has become widely

distributed, and the disease is being recognized with
more and more frequency.

Aside from this, the actual

incidence seems to be growing since men who have been
recognizing the syndrome for a number of years advance
the opinion that it has, of late years, been more
prevalent.

Perhaps this is due to the cumulative effect

of etiological agents such as benzene ring derivatives.
The etiological agents may be divided into four general
classes;

(a} Agranulocytosis:

The idiopathic form of

the disease which shows perhaps the most truly typical
form of the syndrome. {b} Agranulosepsis, which is
caused by bacteria or their products.
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It is probably

rmore true to say just the products since, on normal
animals, bacteria produce the typical septic picture,
and only the products when injected will produce the
entity similiar to the clinical phase of agranulocytosis.
There is also no evidence to show that bacterial
septicemias, when found in these cases, are not really
secondary.

In fact, evidences of the bacteremia have

never been demonstrated before the clinical onset of
the complex.

( c} Agranuloradiation is that form of the

entity developed when excessive X-ray, radium products
or any radioactive substance has been ingested to any
marked degree.

This form of granulopenia is prone to

be accompanied by anemia and effects on the erythroplastio portions of the bone marrow; so many authors
consider it as more truly classed in the realm of
aplastic anemias.

( d} Agranulotoxicosis is that portion

of the syndrome caused by toxic substances such as
benzene and its derivatives.

Small doses of these

substances over periods of time seem to produce the
typical picture.

Larger doses, however, seem to cause

a condition more congruent with complete aplasia of
the bone marrow.

Several investigators believe that in

nearly every case of agranulocytosis a history of one
of these toxins can be gained.
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If this is true, the

class of idiopathic agranulocytosis is being almost
eradicated.

In a review of the literature it is

apparent that many people can and do take tremendous
quantities of these drugs without ill effects upon the
hemopoietic system.

There is, then, undoubtedly a

factor of inherent weakness of t11is system.

As long as

this is true, it is not justified in ruling out completely, at least, agranulocytic angina idiopathica.
The clinical onset is rapid and follows a hematological onset of days to weeks or even months.

The

point of onset as relative to the blood picture is
variable but is usually after the white blood picture
showed fifty percent of its original concentration and
one half of its customary granulocytic element.

The

severity of the symptoms are usually parallel with the
severity of the hemotological deviation.

The onset is

marked with weakness, malaise, lassitude, inertia, etc.
This is followed by sore mouth and subsequent fonnation
of ulcerative lesions in these localities.

The physician

usually finds the patient well advanced in the disease.
The clinical types may be divided into acute fulminating,
with a high mortality; chronic with a low mortality;
acute and chronic recurring, with corresponding mortality
rates; cyclic variety which is regular, periodic; and
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of either the acute or chronic variety with various
gradations of these general classes.

Recovery is rapid

or gradual, depending on the etiology (whether or not
it can be removed), the severeness of the disease, the
condition of the patient, etc.

Death, the other alt er-

native is likewise based on the severity, advancement
and etiology of the syndrome.

Chronic patients may show

only one sign, that of weakness, for years on end.
The pathology of the local lesion is a non-infiltrat ed, denuded, inflamed area.

That of the blood is

a decrease to total lack of granulocytes with a total
decrease of the white blood cells.

The bone marrow

shows a corresponding loss of granulopoietic elements
to a complete aplasia of these factors.

There may or

may not be an associated decrease in the other elements
of the blood.

Some investigators would argue the

associability of this as contiguous with the syndrome,
but when one considers the common origination of all
blood cells, one can readily realize that these related
elements may become affected merely as a matter of course
in the disease itself.

Could one not, therefore, consider

this entity as a step in one of the processes of
production of aplastic anemia?

.And if this is true,

why would not benzol and its derivatives be a true, or
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partial, etiological factor since the degree of benzol
poisoning seems to determine just what type arid how many
of the cellular elements of the marrow and blood are
affected.

Likewise, the spleen and nodes, or the lymph-

atic elements, often show atrophic processes.

Experi-

mental evidence indicates that many of these points are
true.
Treatment of this disease entity has progressed
rather rapidly.

The value of nucleic acid and its

derivatives had been known even before the syndrome
itself was described.

Its application has done much in

offering a better prognosis.
chemotactic in nature.

Its value is chiefly

Glutathione offers a possible

addition in that it might supply the maturation factor.
Both of these factors are supplied with both fetal calf
spleen and yellow bone marrow extract with the latter
being much more successful as far as can now be
determined.

Radiation of the long bones seems to be

stimulatory, but the danger of its use and its inaccessability place it in a less desirable group.

Transfusions

are helpful only as a direct treatment to prolong life
until another form of treatment has time to exert its
influence.

Actual stimulation from blood transfusions

in recovered cases has been reported as beneficial,
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but its possible reaction on the donor makes it.s use ·
of doubtful value from a practical standpoint.

Other

forms of treatment with the exception of local ulcer
treatment are of doubtful value.
Diagnosis is made upon the clinical symptoms, combined with the blood picture.

All other forms can be

ruled out by using these two phases, but all other
diseases can not be ruled out by using only one of them.
For example, the blood picture of aleukemic leukemia
has been confused with that of this syndrome, and some
leukemias with oral sepsis may closely simulate this
disease clinically.
Agranulocytic angina may be rather simply and
accurately diagnosed and may usually be treated successfully as demonstrated by the fall in mortality.

It is,

therefore, a disease in which medical science from an
experimental and clinical angle, should be congratulated.
Yet, much remains to be gathered about its intricate
mechanisms, and even greater success should be procured
with a fuller understanding of this entity.
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r-,
CONCLUSIONS
1.

Agranulocytosis is a disease of recent recognition
but of probably much older history.

2.

Its etiology may be divided into idiopathic agranulocytosis, agranulosepsis, agranulotoxicosis, end
agranuloradiation.

3.

Its clinical course is characterized by weakness,
prostration, inertia, formation of mucous membrane
ulcers and a low white blood count with a granulopenia.

4.

Pathological changes in the bone marrow may be either
conducive with the clinical blood picture which shows
an abnormal maturation factor: or the marrow might
be norm.al or hyperplastic, showing abnormal chemotactic factor.

5.

Diagnosis is made upon clinical symptoms with the
help of the blood picture and perhaps sternal biopsys.

6.

Treatment is successful in so far as the prognosis
has been considerably improved.

The successful

forms of treatment, besides the local management of
ulcers are; Irradation of bones - stimulative but
dangerous in as much as aplasia may be instigated;
Nucleic acid and its derivatives - chemotactic;
Glutathione - maturative;
--~·-----·-·--

Foetal spleen - both

chemotactic and maturative, and yellow bone marrow
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extract, both maturative and chemotact ic and of
greater potency than any of the others.
7.

Prognosis has improved from 100% mortality to 25%
in the last fifteen years.

The prognosis varies

almost directly with the abnormality of the blood
picture and the severity of the attack.
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